The association between plasma amyloid-beta protein (Aβ) and subjective cognitive decline
(SCD) remains controversial. We aimed to explore the correlation between neuroimaging …

Objectives Recent studies regarding the relationships between plasma amyloid-β (Aβ)
levels and cognitive performance had inconsistent results. In this study, we aimed to …

This study investigated the relationships among plasma biomarkers, regional brain atrophy,
and clinical symptoms in patients with Alzheimer's disease (AD; n= 177), mild cognitive …

Background Alzheimer's disease (AD) is characterized by progressive deterioration of
cognitive functions. Some individuals with subjective cognitive decline (SCD) are in the early …

Despite potential implications for the early detection of impending Alzheimer's disease (AD),
very little is known about the differences of large-scale brain networks between amnestic …

Background: Individuals with subjective cognitive decline (SCD) are thought to be the
earliest along the cognitive continuum between healthy aging and Alzheimer's disease (AD) …

Background: Exploring the relationship between Alzheimer's disease (AD) biomarkers and
subjective cognitive decline (SCD) is needed for better defining its clinical meaning in …

We aimed to assess the association between core cerebrospinal fluid (CSF) biomarkers,
regional brain atrophy and clinical severity in the Alzheimer's disease (AD) continuum, as …

Background: Healthy elderly individuals with subjective cognitive decline (SCD) have an
increased risk to develop Alzheimer's disease (AD). There is evidence for AD-type pathology …

Background A disease severity index (SI) for Alzheimer's disease (AD) has been proposed
that summarizes MRI-derived structural measures into a single score using multivariate data …